Lv1
50 积分 2023-07-07 加入
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
1天前
待确认
Vunakizumab: First Approval
1个月前
已完结
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis
2个月前
已完结
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
5个月前
已完结
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
5个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
5个月前
已完结
Clinical research progress of novel biologics for the treatment of lupus nephritis
8个月前
已完结
Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review
8个月前
已完结
Th17细胞与肾脏疾病关系的研究进展
8个月前
已完结
皖公网安备34019202002308
